Synthetic integrin-binding immune stimulators target cancer cells and prevent tumor formation

Immuno-oncology approaches mainly utilize monoclonal antibodies or protein-based scaffolds that bind with high affinity to cancer cells and can generate an immune response. Peptides can also bind with high affinity to cancer cells and are intermediate in size between antibodies and small molecules....

Descripción completa

Detalles Bibliográficos
Autores principales: Brehs, Manuel, Pötgens, André J. G., Steitz, Julia, Thewes, Karine, Schwarz, Janett, Conibear, Anne C., Bartneck, Matthias, Tacke, Frank, Becker, Christian F. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730604/
https://www.ncbi.nlm.nih.gov/pubmed/29242512
http://dx.doi.org/10.1038/s41598-017-17627-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730604/
https://www.ncbi.nlm.nih.gov/pubmed/29242512
http://dx.doi.org/10.1038/s41598-017-17627-0

Ejemplares similares